This observational study aims to understand the genetic causes of polycythemia (too many red blood cells) and thrombocytosis (too many platelets). Researchers want to find specific genes and mutations that lead to these disorders. By identifying these genetic defects, the hope is to develop new treatments and potentially cures. You might be able to join if you have high hemoglobin (a protein in red blood cells) or a high platelet count, and your condition isn't caused by other known medical issues like heart disease. The study is currently unclear on its recruitment status and plans to enroll about 200 participants.

Study design

This is an observational study, meaning researchers will study existing conditions without providing new treatments. It aims to enroll about 200 participants.

What's involved

Participants will have 5-7 teaspoons of blood drawn. This blood will be used for genetic and cell biology analysis.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is to identify molecular defects, measured weekly. It is not specified how long participants will be followed after this.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.